Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Cancer Characteristics In Swedish Families Fulfilling Criteria For Hereditary Nonpolyposis Colorectal Cancer.
J. Bermejo, C. Eng, K. Hemminki
Published 2005 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
BACKGROUND & AIMS The present study quantified the prevalence of families that fulfill the Amsterdam or Bethesda criteria for hereditary nonpolyposis colorectal cancer (HNPCC) in the whole Swedish population and investigated the extent to which tumors in the classified families are HNPCC-related. METHODS The families of the Swedish Family-Cancer Database with at least 4 generations (N = 566,877) were classified according to the Amsterdam and the Bethesda criteria. Survival methods were used to assess the risk of cancer in the classified families, the prognosis of cancer patients, and the risk of subsequent malignancies after colorectal adenomas and after colorectal/endometrial adenocarcinomas. RESULTS The Bethesda criteria identified 0.9% of all Swedish families and 11.2% of patients with colorectal cancer. Families that fulfilled the Bethesda criteria showed increased risks of cancer in the colorectum, endometrium, small bowel, ovary, stomach, bile ducts, renal pelvis, and ureter; members of Bethesda criteria families were at decreased risks of lung and cervical cancers. The prognosis of cancer in the ureter, renal pelvis, stomach, ovary, and colorectum, but not in the endometrium, was better in Bethesda criteria than in nonclassified families. CONCLUSIONS Most malignancies in the classified families reflect typical features of HNPCC (association with subsequent malignancies, accelerated adenoma-carcinoma sequence, and better survival). The data presented in this study should help to define surveillance strategies for members of families that fulfill the criteria for HNPCC testing.
This paper references
Genetic susceptibility to non-polyposis colorectal cancer
H. Lynch (1999)
Testing guidelines for hereditary non-polyposis colorectal cancer
A. Umar (2004)
AGA technical review on hereditary colorectal cancer and genetic testing.
F. Giardiello (2001)
The Swedish Family-Cancer Database: Update, Application to Colorectal Cancer and Clinical Relevance
K. Hemminki (2005)
Extracolonic cancer in hereditary nonpolyposis colorectal cancer
P. Watson (1993)
Systematic review of microsatellite instability and colorectal cancer prognosis.
S. Popat (2005)
Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea.
Y. J. Park (2000)
The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer.
P. Watson (1994)
Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population
K. Lin (1998)
Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium.
A. Millar (1999)
Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.
L. Lipton (2004)
Re: characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases.
K. Hemminki (2001)
de la Chapelle, A.
P. Beighton (1997)
Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer)
J. Mecklin (1991)
Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.
R. Scott (2001)
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.
H. Vasen (1999)
The Swedish Family-Cancer Database
K. Hemminki (2005)
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
H. Vasen (1991)
Estimating effects of probands' characteristics on familial risk: I. Adjustment for censoring and correlated ages at onset
Kung-yee Liang (1991)
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
R. Fishel (1993)
National database of familial cancer in Sweden
K. Hemminki (1998)
Methods for testing familial aggregation of diseases in population‐based samples: application to hodgkin lymphoma in swedish registry data
R. Pfeiffer (2004)
Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility?
S. Levene (2004)
Germ-line msh6 mutations in colorectal cancer families.
R. Kolodner (1999)
Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
L. Aaltonen (1998)
The tumor spectrum in HNPCC.
P. Watson (1994)
Population-based molecular detection of hereditary nonpolyposis colorectal cancer.
R. Salovaara (2000)
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines.
M. Rodriguez-Bigas (1997)
The genetics and natural history of hereditary colon cancer.
J. Lynch (1997)
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
F. Leach (1993)
DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer.
M. Nyström-Lahti (1996)
Distinct PTEN mutational spectra in hereditary non-polyposis colon cancer syndrome-related endometrial carcinomas compared to sporadic microsatellite unstable tumors.
X. Zhou (2002)
Mutation of a mutL homolog in hereditary colon cancer.
N. Papadopoulos (1994)
Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases.
D. Peel (2000)
Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.
S. Winawer (2003)
Clues to the pathogenesis of familial colorectal cancer.
L. Aaltonen (1993)
Identification of HNPCC by Molecular Analysis of Colorectal and Endometrial Tumors
H. Vasen (2004)
Cancer risk in mutation carriers of DNA‐mismatch‐repair genes
M. Aarnio (1999)
The nation-wide Swedish family-cancer database--updated structure and familial rates.
K. Hemminki (2001)
Colorectal cancer screening.
R. Houlston (1999)
Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer
N. Nicolaides (1994)
Analysis for phenotype of HNPCC in China.
Y. Song (2002)
Hereditary colorectal cancer.
H. Lynch (1991)
Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register.
T. Myrhøj (1997)
Prognosis of hereditary nonpolyposis colorectal cancer (HNPCC) and the role of Japanese criteria for HNPCC.
S. Fujita (1996)
Microsatellite instability in cancer of the proximal colon.
S. Thibodeau (1993)
Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations inMSH2 and MLH1
S. Syngal (2000)
Cancer risk in 348 French MSH2 or MLH1 gene carriers
Y. Parc (2003)
Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.
M. Berends (2002)
Familial endometrial cancer in female carriers of MSH6 germline mutations
J. Wijnen (1999)
This paper is referenced by
Familial risks for cancer as the basis for evidence-based clinical referral and counseling.
K. Hemminki (2008)
Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome
D. Huang (2018)
Age of onset in familial cancer.
A. Brandt (2008)
Urinary tract cancer in patients with hereditary non-polyposis colorectal cancer
Peter Zachhau (2012)
Prognostic relevance of MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer patients
A. Russo (2009)
Pathology of Renal Pelvis, Ureter, and Urethra
L. Cheng (2012)
Decision model of segmental compared with total abdominal colectomy for colon cancer in hereditary nonpolyposis colorectal cancer.
Takafumi Maeda (2010)
Familial Associations of Colon and Rectal Cancers With Other Cancers
Hongyao Yu (2019)
Are Women With Endocervical Adenocarcinoma at Risk for Lynch Syndrome? Evaluation of 101 Cases Including Unusual Subtypes and Lower Uterine Segment Tumors
A. Mills (2012)
Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers
R. S. van der Post (2010)
Haematuria in association with Lynch syndrome
M. Ma'ayeh (2012)
Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
O. Lavie (2008)
Mismatch Repair Deficient Cancer Diagnostic Aspects in Colorectal Cancer and the Role of Urological Cancer in Lynch Syndrome
P. Joost (2015)
Lynch syndrome and cervical cancer
Y. Antill (2015)
Management of extracolonic tumours in patients with Lynch syndrome.
J. Koornstra (2009)
Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.
J. Jass (2006)
Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
P. Bonis (2007)
Current World Literature
Hereditary Colorectal Cancer: Registration, Screening and Prognostic Biomarker Analysis
P. Barrow (2015)
Patterns of changing cancer risks with time since diagnosis of a sibling
M. Lee (2015)
Surveillance for urinary tract cancer in Lynch syndrome
I. Bernstein (2013)
Survival in common cancers defined by risk and survival of family members
J. Ji (2011)
Do discordant cancers share familial susceptibility?
K. Hemminki (2012)
Prognostic Relevance of MLH1 and MSH2 Mutations in Hereditary Non-Polyposis Colorectal Cancer Patients
A. Russo (2009)
Intestinal epithelial cell apoptosis due to a hemolytic toxin from Vibrio vulnificus and protection by a 36 kDa glycoprotein from Rhus verniciflua Stokes.
Y. Lee (2019)
Quantitative analysis of the association between sulfotransferase isoform 1A1 polymorphism and risk of urothelial carcinoma.
K. Liu (2015)
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer
Ulrika Andersson (2014)
A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
T. Snowsill (2014)
Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
P. Joost (2015)
Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumour site? Results from two independent databases
P. Gao (2013)
Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico
W. E. De Jesús-Monge (2009)
Behavior of urothelial carcinoma with respect to anatomical location.
J. Catto (2007)See more